Ownership history in UBS AG · 7 quarters on record
This page tracks every 13F SEC filing in which UBS AG reported a position in CIPHERGEN BIOSYSTEMS INC COM (CIPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2007 Q2 | REDUCED | 2 | -78 | -97.5% | 0.00% | $9 | — |
| 2006 Q4 | ADDED | 80 | +23 | +40.4% | 0.00% | $17 | — |
| 2006 Q3 | REDUCED | 57 | -1 | -1.7% | 0.00% | $19 | — |
| 2006 Q1 | REDUCED | 58 | -1,579 | -96.5% | 0.00% | $5 | — |
| 2005 Q4 | ADDED | 1,637 | +1,636 | +163600.0% | 0.00% | $2K | — |
| 2005 Q3 | REDUCED | 1 | -6,722 | -100.0% | 0.00% | $1 | — |
| 2005 Q2 | INITIATED | 6,723 | — | — | 0.00% | $13K | — |
As of 2007 Q2 — sorted by position size